Recombinant Human SOD3 Protein，His

SOD3, or superoxide dismutase 3, is a critical extracellular antioxidant enzyme that plays a vital role in protecting tissues from oxidative stress by catalyzing the dismutation of superoxide radicals into hydrogen peroxide and oxygen. Research on SOD3 has gained significant attention due to its potential therapeutic applications in various diseases associated with oxidative damage, such as cardiovascular diseases, neurodegenerative disorders, and inflammatory conditions. The enzyme is predominantly expressed in the extracellular matrix and is essential for maintaining redox homeostasis. Studies have shown that reduced SOD3 activity is linked to increased susceptibility to oxidative stress-related diseases. Therefore, recombinantly produced SOD3 has been explored for its potential in clinical therapies, allowing for detailed investigation into its structure-function relationship and mechanisms of action. The production of SOD3 as a recombinant protein facilitates large-scale studies, allowing researchers to examine its antioxidant properties, stability, and interactions with other biomolecules. Additionally, therapeutic approaches involving SOD3, such as gene therapy or the use of SOD3 mimetics, hold promise for enhancing the enzyme's protective effects in pathological conditions. Overall, the ongoing research on SOD3 recombinant protein underscores its significance in oxidative stress management and its potential as a target for novel therapeutic strategies.